# Sage Capital

> Sage Capital is a VC fund in St Louis backing Genetics, Biopharma and Industrial. See 2 investments, round sizes, portfolio. Updated Oct 2026.

- Type: VC Fund
- Location: St Louis, United States
- Total investments: 2
- Last investment: Nov 2015
- Lead investor: 0%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/company/sage-capital-llc
- Website: https://www.sagecapitalllc.com

Sage Capital is a private equity firm providing long-term capital and expertise for small and middle market businesses in North America.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Genetics | 1 | 50% |
| Biopharma | 1 | 50% |
| Industrial | 1 | 50% |
| Biotechnology | 1 | 50% |
| Manufacturing | 1 | 50% |

6 industries tracked in total.

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Shenzhen Uni-medica Technology Co. | Shenzhen Uni-medica Technology Co., Ltd specializes in the development, production, and distribution of high-end in vitro diagnostic reagents and instruments. The company focuses on providing integrated diagnostic solutions that cater to various clinical needs. With a commitment to innovation and quality, Shenzhen Uni-medica Technology Co., Ltd hasachieved national high-tech enterprise status. The product range includes rapid extraction kits with a processing time of 10 minutes, ensuring efficiency in diagnostic procedures. The company serves a global market, including regions such as Africa, Americas, Asia, Europe, and the Middle East. It holds significant certifications such as EC REP and ISO 9001, underscoring its adherence to international standards in product quality and management systems. |  | Series A | Nov 01, 2015 | https://www.unimed-global.com |
| Bontai Biotechnology | Bontai Biotechnology focuses on the production and sales of biosynthetic technologies and products. |  | Series A | Apr 01, 2015 | https://www.bontac-bio.com/index.aspx |

2 of 2 investments shown.

## Co-investors
- [Fang Fund Partners](https://shizune.co/investors/profile/fang-fund-partners) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Sage Capital invest in?

Sage Capital invests primarily in Genetics, Biopharma and Industrial startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sage Capital last invest?

The most recent investment recorded for Sage Capital closed in Nov 2015. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co